Skip to Content

A Validation Study of a Korean Version of the Brief Fatigue Inventory and the MD Anderson Symptom Inventory

Principal Investigator: Xin Shelley Wang, M.D., M.P.H.

The goal of this study is to establish the validation of two symptom assessment instruments and look at symptoms related to cancer and its treatment in Korea.

Specific Objectives

  • To validate a Korean version of the Brief Fatigue Inventory (BFI) using a sample of normal community dwelling adults and a sample of patients with different types of cancer undergoing different types of treatment, who currently have fatigue, and thus produce an instrument that is sensitive, reliable and valid for use in future clinical trials assessing fatigue
  • To validate a Korean version of MD Anderson Symptom Inventory (MDASI) using patients with different types of cancer undergoing different types of treatment, and who have different levels of severity of symptoms other than fatigue, and thus produce an instrument that is sensitive, reliable and valid for use in future clinical trials assessing multiple symptoms

Methods

This validation study included a one-time survey of a sample of outpatients and inpatients with both hematological and solid tumor type diseases at Philippine General Hospital in Manila. We will also survey a group of age matched community dwelling adults that will be identified through local community organizations.

Measurements

Instruments included the Brief Fatigue Inventory (BFI), the Brief Pain Inventory (BPI), the EORTC and the MD Anderson Symptom Inventory (MDASI).

For more information

Contact Xin Shelley Wang, M.D., M.P.H., at swong@mdanderson.org


© 2014 The University of Texas MD Anderson Cancer Center